Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NECTAR: Nelarabine, Etoposide, and Cyclophosphamide in Relapsed T-ALL/T-LL
NCT00981799Phase 2Terminated
- Sponsor
- Therapeutic Advances in Childhood Leukemia and Lymphoma Consortium
- Start
- Jun 2010
- Primary completion
- Nov 2015
- Modality
- Prodrugs/Conditional Activator Small Molecules, Orthosteric Ligands
- Countries
- 7
01
Overview
A Phase 2 trial of nelarabine in t-cell acute lymphoblastic leukemia (T-ALL), T cell lymphoblastic lymphoma (T-LBL), sponsored by Therapeutic Advances in Childhood Leukemia and Lymphoma Consortium. Started Jun 2010; status: terminated.
02
Drugs
nelarabine
03
Conditions
t-cell acute lymphoblastic leukemia (T-ALL)T cell lymphoblastic lymphoma (T-LBL)
Beyond the preview
Go deeper on NCT00981799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00981799.